TY - JOUR
T1 - Modulation of Rat 50-kHz Ultrasonic Vocalizations by Glucocorticoid Signaling: Possible Relevance to Reward and Motivation
AU - Simola, Nicola
AU - Paci, Elena
AU - Serra, Marcello
AU - Costa, Giulia
AU - Morelli, Micaela
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Background: Rats emit 50-kHz ultrasonic vocalizations (USVs) to communicate positive emotional states, and these USVs are increasingly being investigated in preclinical studies on reward and motivation. Although it is the activation of dopamine receptors that initiates the emission of 50-kHz USVs, non-dopaminergic mechanisms may modulate calling in the 50 kHz frequency band. To further elucidate these mechanisms, the present study investigated whether the pharmacological manipulation of glucocorticoid signaling influenced calling. Methods: Rats were administered corticosterone (1-5 mg/kg, s.c.), the glucocorticoid receptor antagonist mifepristone (40 or 100 mg/kg, s.c.), or the corticosterone synthesis inhibitor metyrapone (50 or 100 mg/kg, i.p.). The effects of these drugs on calling initiation and on calling recorded during nonaggressive social contacts or after the administration of amphetamine (0.25 or 1 mg/kg, i.p.) were then evaluated. Results: Corticosterone failed to initiate the emission of 50-kHz USVs and did not influence pro-social and amphetaminestimulated calling. Similarly, mifepristone and metyrapone did not initiate calling. However, metyrapone suppressed prosocial calling and calling stimulated by a moderate dose (1 mg/kg, i.p.) of amphetamine. Conversely, mifepristone attenuated calling stimulated by a low (0.25 mg/kg, i.p.), but not moderate (1 mg/kg, i.p.), dose of amphetamine and had no influence on pro-social calling. Conclusions: The present results demonstrate that glucocorticoid signaling modulates calling in the 50 kHz frequency band only in certain conditions and suggest that mechanisms different from the inhibition of corticosterone synthesis mayparticipate in the suppression of calling by metyrapone.
AB - Background: Rats emit 50-kHz ultrasonic vocalizations (USVs) to communicate positive emotional states, and these USVs are increasingly being investigated in preclinical studies on reward and motivation. Although it is the activation of dopamine receptors that initiates the emission of 50-kHz USVs, non-dopaminergic mechanisms may modulate calling in the 50 kHz frequency band. To further elucidate these mechanisms, the present study investigated whether the pharmacological manipulation of glucocorticoid signaling influenced calling. Methods: Rats were administered corticosterone (1-5 mg/kg, s.c.), the glucocorticoid receptor antagonist mifepristone (40 or 100 mg/kg, s.c.), or the corticosterone synthesis inhibitor metyrapone (50 or 100 mg/kg, i.p.). The effects of these drugs on calling initiation and on calling recorded during nonaggressive social contacts or after the administration of amphetamine (0.25 or 1 mg/kg, i.p.) were then evaluated. Results: Corticosterone failed to initiate the emission of 50-kHz USVs and did not influence pro-social and amphetaminestimulated calling. Similarly, mifepristone and metyrapone did not initiate calling. However, metyrapone suppressed prosocial calling and calling stimulated by a moderate dose (1 mg/kg, i.p.) of amphetamine. Conversely, mifepristone attenuated calling stimulated by a low (0.25 mg/kg, i.p.), but not moderate (1 mg/kg, i.p.), dose of amphetamine and had no influence on pro-social calling. Conclusions: The present results demonstrate that glucocorticoid signaling modulates calling in the 50 kHz frequency band only in certain conditions and suggest that mechanisms different from the inhibition of corticosterone synthesis mayparticipate in the suppression of calling by metyrapone.
KW - amphetamine
KW - corticosterone
KW - metyrapone
KW - mifepristone
KW - rat communication
UR - https://www.scopus.com/pages/publications/85041168362
U2 - 10.1093/ijnp/pyx106
DO - 10.1093/ijnp/pyx106
M3 - Article (Academic Journal)
C2 - 29182715
AN - SCOPUS:85041168362
SN - 1461-1457
VL - 21
SP - 73
EP - 83
JO - International Journal of Neuropsychopharmacology
JF - International Journal of Neuropsychopharmacology
IS - 1
M1 - pyx106
ER -